Clarity Pharmaceuticals Ltd (ASX: CU6)
Australia
· Delayed Price · Currency is AUD
5.97
-0.09 (-1.49%)
Nov 21, 2024, 4:10 PM AEST
Clarity Pharmaceuticals Market Cap
Clarity Pharmaceuticals has a market cap or net worth of 1.91 billion as of November 21, 2024. Its market cap has increased by 551.82% in one year.
Market Cap
1.91B
Enterprise Value
1.78B
Revenue
11.51M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.97
Market Cap Chart
Since August 25, 2021, Clarity Pharmaceuticals's market cap has increased from 384.20M to 1.91B, an increase of 397.57%. That is a compound annual growth rate of 63.99%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Nov 21, 2024 | 1.91B | 283.67% |
Dec 29, 2023 | 498.26M | 93.82% |
Dec 30, 2022 | 257.07M | 35.63% |
Dec 31, 2021 | 189.54M | -50.67% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
CSL Limited | 132.54B |
ResMed Inc. | 54.63B |
Pro Medicus Limited | 22.43B |
Fisher & Paykel Healthcare Corporation Limited | 19.59B |
Cochlear Limited | 19.18B |
Sonic Healthcare Limited | 13.28B |
Ramsay Health Care Limited | 8.65B |
Telix Pharmaceuticals Limited | 7.68B |